CLASS II Device recall · Reported 31 Aug 2016 · FDA Enforcement Report

Radiesse (+) Lidocaine, Injectable Implant 1.5cc recalled

Merz North America is recalling Radiesse (+) Lidocaine, Injectable Implant 1.5cc, distributed nationwide in the US. The recall was initiated on 20 May 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel number: 8063M0K1, Lot #100088744.
Quantity recalled1,591 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2607-2016
FDA event ID
74252
Recalling firm
Merz North America, Raleigh, NC
Classification
Class II
Status
Terminated
Recall initiated
20 May 2016
FDA classified
19 Aug 2016
Reported
31 Aug 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 May 2016Recall initiated by company
19 Aug 2016Classified by FDA+91 days
31 Aug 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.

Product as listed by the FDA

Radiesse (+) Lidocaine, Injectable Implant 1.5cc, Rx only, P/N: 8063M0K1, Merz Aesthetics. Product Usage: RADIESSE is indicated for sub-dermal implantation for the correction of moderate to severe facial wrinkles and folds.

Where it was distributed

US Nationwide Distribution in the states of AR, CA, CO, CT, DC, FL, GA, IL, IN, LA, MA, MD, MI, MN, MO, NC, ND, NJ, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT and WA.

Nationwide ArkansasCaliforniaColoradoConnecticutDistrict of ColumbiaFloridaGeorgiaIllinoisIndianaLouisianaMassachusettsMarylandMichiganMinnesotaMissouriNorth CarolinaNorth DakotaNew JerseyNevadaNew York

Questions about this recall

Why was it recalled?

Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.

Which lots are affected?

Model number: 8063M0K1, Lot #100088744.

Where was it sold?

US Nationwide Distribution in the states of AR, CA, CO, CT, DC, FL, GA, IL, IN, LA, MA, MD, MI, MN, MO, NC, ND, NJ, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT and WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Merz North America

All 5

Other Other Medical Devices recalls

All 13,778